Montelukast Evolugen (Montelukast Sodium)

Montelukast sodium acts as a selective antagonist of the cysteinyl leukotriene receptor CysLT1. By blocking leukotriene D4 and related mediators, it prevents the cascade that leads to bronchoconstriction, mucus secretion, and airway inflammation, thereby improving breathing.

The specific dose of Montelukast Evolugen is determined by the prescribing clinician based on the patient’s age, condition severity, and response to therapy. Healthcare providers set the appropriate regimen according to approved guidelines.

Montelukast is classified as Pregnancy Category B, indicating no evidence of risk in animal studies but limited human data. It may be used during pregnancy only if clearly needed. Caution is advised for nursing mothers; the benefit‑risk balance should be evaluated by a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients with allergic components or those who prefer a once‑daily tablet, though it may be less potent for acute symptom relief compared with inhaled bronchodilators.

Montelukast Evolugen should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Montelukast Evolugen is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or broken unless specifically instructed by a healthcare provider.

Serious risks, though rare, include angioedema, severe allergic reactions, mood changes such as depression or suicidal thoughts, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience swelling, rash, or significant mood alterations.

Montelukast Evolugen is contraindicated in individuals with known hypersensitivity to montelukast sodium or any of its excipients. It should be used with caution in patients with severe hepatic impairment and is not recommended for acute asthma attacks where rapid bronchodilation is required.